Previous 10 | Next 10 |
NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has increased its stake in its legacy LegalSimpli Software subsidiary from 51% to 82.6%, largely from the conversion of long-term debt held b...
NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, reported preliminary unaudited results for its fourth quarter and full year ended December 31, 2020. Revenue for the fourth quarter is ...
Conversion Labs (CVLB) appoints Dr. Anthony Puopolo to the new position of chief medical officer.He brings to the company more than 20 years of executive and professional healthcare experience, including serving in senior leadership positions at several medical instit...
NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and psychiatrist, Dr. Anthony Puopolo , to the new position of chief medical officer....
Gainers: SOS (SOS) +73%, Oragenics (OGEN) +41%, Oxford Immunotec Global OXFD +27%, Akerna (KERN) +25%, Conversion Labs (CVLB) +22%.Losers: Addex Therapeutics ADXN -22%, NeuroBo Pharmaceuticals NRBO -12%, ViewRay (VRAY) -11%, Hel...
NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has been invited to present at H.C. Wainwright’s BioConnect Conference being held virtually on January 11-14, 2021. The company’s ...
Conversion Labs ([[CVLB]] +1.2%) appointed digital marketing expert and 20-years industry veteran Bryant Hussey to a new position, chief digital officer, for leading the company's marketing and customer retention efforts and launch new or enhanced telemedicine products, improve unit econ...
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed digital marketing expert and industry thought-leader, Bryant Hussey , to the new position of chief digital officer. He will lead the company...
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, reported its annualized revenue run-rate reached a record $53.9 million in November, up 332% versus $12.5 million for all of 2019. The r...
NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its new Veritas MD telehealth platform, opening the door to greater market expansion with a growing port...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17...
NEW YORK, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the official launch of its subscription-based primary care and concierge ser...
NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Piñeiro Dagnery, who will continu...